EXAS logo

EXAS
Exact Sciences Corp.

11,198
Mkt Cap
$19.8B
Volume
2.61M
52W High
$103.75
52W Low
$38.81
PE Ratio
-93.89
EXAS Fundamentals
Price
$103.37
Prev Close
$103.71
Open
$103.60
50D MA
$102.65
Beta
0.82
Avg. Volume
2.25M
EPS (Annual)
-$1.10
P/B
8.24
Rev/Employee
$450,970.83
$20,733.24
Loading...
Loading...
News
all
press releases
Exact Sciences (NASDAQ:EXAS) Sets New 12-Month High - Should You Buy?
Exact Sciences (NASDAQ:EXAS) Reaches New 52-Week High - Still a Buy...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Exact Sciences Corporation (NASDAQ:EXAS) Receives Average Recommendation of "Reduce" from Brokerages
Exact Sciences Corporation (NASDAQ:EXAS - Get Free Report) has been given an average recommendation of "Reduce" by the twenty-two ratings firms that are presently covering the firm, MarketBeat...
MarketBeat·2d ago
News Placeholder
Exact Sciences Corporation $EXAS Shares Bought by Fisher Asset Management LLC
Fisher Asset Management LLC raised its holdings in shares of Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 25.5% in the 3rd quarter, according to the company in its most recent 13F filing...
MarketBeat·6d ago
News Placeholder
Exact Sciences Corporation $EXAS Stock Position Lifted by ARK Investment Management LLC
ARK Investment Management LLC lifted its stake in shares of Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 6,072,588.9% during the third quarter, according to the company in its most...
MarketBeat·6d ago
News Placeholder
CSLLY or EXAS: Which Is the Better Value Stock Right Now?
CSLLY vs. EXAS: Which Stock Is the Better Value Option?
Zacks·6d ago
News Placeholder
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it has earned the 2026 Gallup Exceptional Workplace Award (GEWA), marking the third...
Business Wire·6d ago
News Placeholder
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration
Amalgam Rx, Inc., a leader in data-driven, AI-powered healthcare engagement and clinical decision support, today announced results from a Privia Health (NASDAQ: PRVA)-led colorectal cancer (CRC...
Business Wire·7d ago
News Placeholder
TD Asset Management Inc Reduces Holdings in Exact Sciences Corporation $EXAS
TD Asset Management Inc reduced its holdings in shares of Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 21.8% in the third quarter, according to the company in its most recent 13F filing...
MarketBeat·7d ago
News Placeholder
Rafferty Asset Management LLC Sells 25,740 Shares of Exact Sciences Corporation $EXAS
Rafferty Asset Management LLC lessened its stake in Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 14.9% during the third quarter, according to its most recent Form 13F filing with the...
MarketBeat·8d ago
News Placeholder
Exact Sciences Corporation $EXAS Shares Sold by Fox Run Management L.L.C.
Fox Run Management L.L.C. cut its position in Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 77.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The...
MarketBeat·8d ago
<
1
2
...
>

Latest EXAS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.